Research graph
References from Deprescribing interventions in older adults with cancer: A systematic review and meta-analysis. Local targets link to admitted publications; unresolved targets remain external evidence.
What is polypharmacy? A systematic review of definitions
10.1186/s12877-017-0621-2 · 2017 · External reference
Study: polypharmacy nearly doubled in 20 years among older adults in US
2024 · External reference
An overview of prevalence, determinants and health outcomes of polypharmacy
10.1177/2042098620933741 · 2020 · External reference
The relationship between frailty and polypharmacy in older people: A systematic review
10.1111/bcp.13590 · 2018 · External reference
An update on the clinical consequences of polypharmacy in older adults: a narrative review
10.1080/14740338.2018.1546841 · 2018 · External reference
Association between polypharmacy and falls in older adults: a longitudinal study from England
10.1136/bmjopen-2017-016358 · 2017 · External reference
Clinical consequences of polypharmacy in elderly
10.1517/14740338.2013.827660 · 2014 · External reference
Hospitalisation and adverse drug events in a geriatric oncology setting: A systematic review of the literature
10.1016/j.sapharm.2024.04.018 · 2024 · External reference
Optimising pharmacotherapy in older cancer patients with polypharmacy
2020 · External reference
Associations of polypharmacy and inappropriate medications with adverse outcomes in older adults with cancer: a systematic review and meta-analysis
10.1634/theoncologist.2019-0406 · 2019 · External reference
Polypharmacy and trajectories of health-related quality of life in older adults: an Australian cohort study
10.1007/s11136-022-03136-9 · 2022 · External reference
Medication adherence to multidrug regimens
10.1016/j.cger.2012.01.008 · 2012 · External reference
Medication non-adherence in older adults: underlying factors, potential interventions and outcomes
10.1007/s40266-025-01249-7 · 2025 · External reference
Association of polypharmacy with colorectal cancer survival among older patients
10.1002/onco.13961 · 2021 · External reference
Impact of multimorbidity and polypharmacy on mortality after cancer: a nationwide registry-based cohort study in Denmark 2005–2017
10.1080/0284186x.2023.2270145 · 2023 · External reference
Polypharmacy and the management of the older cancer patient
10.1093/annonc/mdt266 · 2013 · External reference
Polypharmacy, potentially inappropriate medications, and drug-drug interactions in vulnerable older adults with advanced cancer initiating cancer treatment
10.1093/oncolo/oyac053 · 2022 · External reference
Factors associated with the use of potentially inappropriate medications by older adults with cancer
10.1016/j.jgo.2017.05.003 · 2017 · External reference
A systematic review of the emerging definition of ‘deprescribing’ with network analysis: implications for future research and clinical practice
10.1111/bcp.12732 · 2015 · External reference
A systematic review of randomised-controlled trials on deprescribing outcomes in older adults with polypharmacy
10.1093/ijpp/riad025 · 2023 · External reference
Efficacy of deprescribing on health outcomes: an umbrella review of systematic reviews with meta-analysis of randomized controlled trials
10.1016/j.arr.2024.102237 · 2024 · External reference
Deprescribing interventions for older patients: a systematic review and meta-analysis
10.1016/j.jamda.2023.07.016 · 2023 · External reference
Deprescribing in hospitalized patients with cancer: a clinical pharmacist-initiated multidisciplinary intervention
10.1177/10781552241294016 · 2026 · External reference
Pharmacist-led medication assessment and deprescribing intervention for older adults with cancer and polypharmacy: a pilot study
2018 · External reference
Deprescribing: a prime opportunity to optimize care of cancer patients
10.3390/curroncol30110704 · 2023 · External reference
The U.S. deprescribing research network: catalyzing research and action to optimize medication use in older adults
10.1111/jgs.18856 · 2024 · External reference
10.18773/austprescr.2025.055
10.18773/austprescr.2025.055 · 2025 · External reference
Reducing inappropriate polypharmacy for older patients at specialist outpatient clinics: a systematic review
10.1080/03007995.2023.2185390 · 2023 · External reference
Rationalizing prescription via deprescribing in oncology practice
10.1177/10781552231207839 · 2023 · External reference
Deprescribing in older adults with cancer and limited life expectancy: an integrative review
10.1177/10499091211003078 · 2021 · External reference
Impact of pharmaceutical care interventions on multidisciplinary care of older patients with cancer: a systematic review
10.1016/j.jgo.2023.101450 · 2023 · External reference
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
10.1186/s13643-021-01626-4 · 2021 · External reference
Development and validation of search filters to retrieve medication discontinuation articles in Medline and Embase
10.1111/hir.12516 · 2024 · External reference
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
2016 · External reference
RoB 2: a revised tool for assessing risk of bias in randomised trials
2019 · External reference
Impact of a pharmacist and geriatrician medication review on drug-related problems in older outpatients with cancer
10.1016/j.jgo.2020.07.010 · 2021 · External reference
Drugs prescribed for patients hospitalized in a geriatric oncology unit: potentially inappropriate medications and impact of a clinical pharmacist
10.1016/j.jgo.2016.05.001 · 2016 · External reference
Polypharmacy in hospitalized older adult cancer patients: experience from a prospective, observational study of an oncology-acute care for elders unit
10.1016/j.amjopharm.2009.05.002 · 2009 · External reference
Optimizing medication therapy in elderly patients: the impact of medication review using STOPP and START criteria version 2
10.1177/10781552241296882 · 2026 · External reference
Clinical impact and cost-saving analysis of a comprehensive pharmaceutical care intervention in older patients with cancer
10.1111/jgs.18585 · 2024 · External reference
Pilot randomized trial of a pharmacy intervention for older adults with cancer
10.1634/theoncologist.2018-0408 · 2019 · External reference
Tools for evaluating potentially inappropriate medication use in older adults: a scoping review assessing suitability for register-based research
10.1111/bcpt.70094 · 2025 · External reference
Deprescribing tools: a review of the types of tools available to aid deprescribing in clinical practice
10.1002/jppr.1626 · 2020 · External reference
Prescription of potentially inappropriate medication use in older cancer outpatients with multimorbidity: concordance among the Chinese, AGS/beers, and STOPP criteria
2022 · External reference
Performance of potentially inappropriate medications assessment tools in older Indian patients with cancer
10.1002/cam4.6797 · 2024 · External reference
Prescription of potentially inappropriate medication in older inpatients of an internal medicine ward: concordance and overlap among the EU(7)-PIM list and beers and STOPP criteria
10.3389/fphar.2021.676020 · 2021 · External reference
Ageing-related considerations for medication used in supportive care in cancer
10.1016/j.jgo.2024.101760 · 2024 · External reference
STOPP/START criteria for potentially inappropriate prescribing in older people: version 2
10.1093/ageing/afu145 · 2015 · External reference
The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis
10.1111/bcp.12975 · 2016 · External reference
Cumulative update of a systematic overview evaluating interventions addressing polypharmacy
10.1001/jamanetworkopen.2023.50963 · 2024 · External reference
Impact of a tripartite collaboration between oncologist, pharmacist and diabetologist in the management of patients with diabetes starting chemotherapy: the ONCODIAB trial
10.3390/cancers15184544 · 2023 · External reference
Assessing the impact of a designated pharmacist intervention on drug treatment costs and technical efficiency in the hemato-oncology outpatient clinic
2024 · External reference
Preliminary guidelines for the detection and management of drug-related problems in cancer patients with type 2 diabetes mellitus: a practical resource for oncology pharmacists
2024 · External reference
Patients âgés et anticancéreux injectables : étude de faisabilité de la mise en place d’entretiens pharmaceutiques d’oncogériatrie dans un centre hospitalier
10.1016/j.bulcan.2024.03.001 · 2024 · External reference
Implementing a pharmacist-led, individualized medication assessment and planning (iMAP) intervention to reduce medication related problems among older adults with cancer
10.1016/j.jgo.2017.04.005 · 2017 · External reference
Older adults’ awareness of deprescribing: a population-based survey
10.1111/jgs.15079 · 2017 · External reference
Policies for deprescribing: an international scan of intended and unintended outcomes of limiting sedative-hypnotic use in community-dwelling older adults
10.12927/hcpol.2019.25857 · 2019 · External reference
The MedSafer study—electronic decision support for deprescribing in hospitalized older adults: a cluster randomized clinical trial
10.1001/jamainternmed.2021.7429 · 2022 · External reference
Deprescribing potentially inappropriate medications in memory clinic patients (DePIMM): a feasibility study
10.1016/j.sapharm.2020.01.010 · 2020 · External reference
Barriers and facilitators of deprescribing for older adults with cancer and polypharmacy
10.1016/j.jgo.2026.102933 · 2026 · External reference
Attitudes and barriers towards deprescribing in older patients experiencing polypharmacy: a narrative review
10.1038/s41514-023-00132-2 · 2024 · External reference
Optimising medications for patients with cancer and multimorbidity: the case for deprescribing
10.1016/j.clon.2020.05.015 · 2020 · External reference
The educational needs of pharmacists to optimize medication usage in older adults with cancer: a scoping review by the International Society of Geriatric Oncology Nursing, Allied Health, and Scientists pharmacy group
10.1016/j.jgo.2026.103026 · 2026 · External reference
Integrated Geriatric Assessment and Treatment Effectiveness (INTEGERATE) in older people with cancer starting systemic anticancer treatment in Australia: a multicentre, open-label, randomised controlled trial
10.1016/s2666-7568(22)00169-6 · 2022 · External reference
The effect of geriatric intervention in frail older patients receiving chemotherapy for colorectal cancer: a randomised trial (GERICO)
10.1038/s41416-021-01367-0 · 2021 · External reference
The MedSafer study—electronic decision support for deprescribing in hospitalized older adults: a cluster randomized clinical trial
10.1001/jamainternmed.2021.7429 · ExternalCitation · doi-reference
Cumulative update of a systematic overview evaluating interventions addressing polypharmacy
10.1001/jamanetworkopen.2023.50963 · ExternalCitation · doi-reference
Performance of potentially inappropriate medications assessment tools in older Indian patients with cancer
10.1002/cam4.6797 · ExternalCitation · doi-reference
Deprescribing tools: a review of the types of tools available to aid deprescribing in clinical practice
10.1002/jppr.1626 · ExternalCitation · doi-reference
Association of polypharmacy with colorectal cancer survival among older patients
10.1002/onco.13961 · ExternalCitation · doi-reference
Polypharmacy and trajectories of health-related quality of life in older adults: an Australian cohort study
10.1007/s11136-022-03136-9 · ExternalCitation · doi-reference
Medication non-adherence in older adults: underlying factors, potential interventions and outcomes
10.1007/s40266-025-01249-7 · ExternalCitation · doi-reference
Polypharmacy in hospitalized older adult cancer patients: experience from a prospective, observational study of an oncology-acute care for elders unit
10.1016/j.amjopharm.2009.05.002 · ExternalCitation · doi-reference
Efficacy of deprescribing on health outcomes: an umbrella review of systematic reviews with meta-analysis of randomized controlled trials
10.1016/j.arr.2024.102237 · ExternalCitation · doi-reference
Patients âgés et anticancéreux injectables : étude de faisabilité de la mise en place d’entretiens pharmaceutiques d’oncogériatrie dans un centre hospitalier
10.1016/j.bulcan.2024.03.001 · ExternalCitation · doi-reference
Medication adherence to multidrug regimens
10.1016/j.cger.2012.01.008 · ExternalCitation · doi-reference
Optimising medications for patients with cancer and multimorbidity: the case for deprescribing
10.1016/j.clon.2020.05.015 · ExternalCitation · doi-reference
Deprescribing interventions for older patients: a systematic review and meta-analysis
10.1016/j.jamda.2023.07.016 · ExternalCitation · doi-reference
Drugs prescribed for patients hospitalized in a geriatric oncology unit: potentially inappropriate medications and impact of a clinical pharmacist
10.1016/j.jgo.2016.05.001 · ExternalCitation · doi-reference
Implementing a pharmacist-led, individualized medication assessment and planning (iMAP) intervention to reduce medication related problems among older adults with cancer
10.1016/j.jgo.2017.04.005 · ExternalCitation · doi-reference
Factors associated with the use of potentially inappropriate medications by older adults with cancer
10.1016/j.jgo.2017.05.003 · ExternalCitation · doi-reference
Impact of a pharmacist and geriatrician medication review on drug-related problems in older outpatients with cancer
10.1016/j.jgo.2020.07.010 · ExternalCitation · doi-reference
Impact of pharmaceutical care interventions on multidisciplinary care of older patients with cancer: a systematic review
10.1016/j.jgo.2023.101450 · ExternalCitation · doi-reference
Ageing-related considerations for medication used in supportive care in cancer
10.1016/j.jgo.2024.101760 · ExternalCitation · doi-reference
Barriers and facilitators of deprescribing for older adults with cancer and polypharmacy
10.1016/j.jgo.2026.102933 · ExternalCitation · doi-reference
The educational needs of pharmacists to optimize medication usage in older adults with cancer: a scoping review by the International Society of Geriatric Oncology Nursing, Allied Health, and Scientists pharmacy group
10.1016/j.jgo.2026.103026 · ExternalCitation · doi-reference
Deprescribing potentially inappropriate medications in memory clinic patients (DePIMM): a feasibility study
10.1016/j.sapharm.2020.01.010 · ExternalCitation · doi-reference
Hospitalisation and adverse drug events in a geriatric oncology setting: A systematic review of the literature
10.1016/j.sapharm.2024.04.018 · ExternalCitation · doi-reference
Integrated Geriatric Assessment and Treatment Effectiveness (INTEGERATE) in older people with cancer starting systemic anticancer treatment in Australia: a multicentre, open-label, randomised controlled trial
10.1016/s2666-7568(22)00169-6 · ExternalCitation · doi-reference
The effect of geriatric intervention in frail older patients receiving chemotherapy for colorectal cancer: a randomised trial (GERICO)
10.1038/s41416-021-01367-0 · ExternalCitation · doi-reference
Attitudes and barriers towards deprescribing in older patients experiencing polypharmacy: a narrative review
10.1038/s41514-023-00132-2 · ExternalCitation · doi-reference
Impact of multimorbidity and polypharmacy on mortality after cancer: a nationwide registry-based cohort study in Denmark 2005–2017
10.1080/0284186x.2023.2270145 · ExternalCitation · doi-reference
Reducing inappropriate polypharmacy for older patients at specialist outpatient clinics: a systematic review
10.1080/03007995.2023.2185390 · ExternalCitation · doi-reference
An update on the clinical consequences of polypharmacy in older adults: a narrative review
10.1080/14740338.2018.1546841 · ExternalCitation · doi-reference
STOPP/START criteria for potentially inappropriate prescribing in older people: version 2
10.1093/ageing/afu145 · ExternalCitation · doi-reference
Polypharmacy and the management of the older cancer patient
10.1093/annonc/mdt266 · ExternalCitation · doi-reference
A systematic review of randomised-controlled trials on deprescribing outcomes in older adults with polypharmacy
10.1093/ijpp/riad025 · ExternalCitation · doi-reference
Polypharmacy, potentially inappropriate medications, and drug-drug interactions in vulnerable older adults with advanced cancer initiating cancer treatment
10.1093/oncolo/oyac053 · ExternalCitation · doi-reference
A systematic review of the emerging definition of ‘deprescribing’ with network analysis: implications for future research and clinical practice
10.1111/bcp.12732 · ExternalCitation · doi-reference
The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis
10.1111/bcp.12975 · ExternalCitation · doi-reference
The relationship between frailty and polypharmacy in older people: A systematic review
10.1111/bcp.13590 · ExternalCitation · doi-reference
Tools for evaluating potentially inappropriate medication use in older adults: a scoping review assessing suitability for register-based research
10.1111/bcpt.70094 · ExternalCitation · doi-reference
Development and validation of search filters to retrieve medication discontinuation articles in Medline and Embase
10.1111/hir.12516 · ExternalCitation · doi-reference
Older adults’ awareness of deprescribing: a population-based survey
10.1111/jgs.15079 · ExternalCitation · doi-reference
Clinical impact and cost-saving analysis of a comprehensive pharmaceutical care intervention in older patients with cancer
10.1111/jgs.18585 · ExternalCitation · doi-reference
The U.S. deprescribing research network: catalyzing research and action to optimize medication use in older adults
10.1111/jgs.18856 · ExternalCitation · doi-reference
Association between polypharmacy and falls in older adults: a longitudinal study from England
10.1136/bmjopen-2017-016358 · ExternalCitation · doi-reference
Deprescribing in older adults with cancer and limited life expectancy: an integrative review
10.1177/10499091211003078 · ExternalCitation · doi-reference
Rationalizing prescription via deprescribing in oncology practice
10.1177/10781552231207839 · ExternalCitation · doi-reference
Deprescribing in hospitalized patients with cancer: a clinical pharmacist-initiated multidisciplinary intervention
10.1177/10781552241294016 · ExternalCitation · doi-reference
Optimizing medication therapy in elderly patients: the impact of medication review using STOPP and START criteria version 2
10.1177/10781552241296882 · ExternalCitation · doi-reference
An overview of prevalence, determinants and health outcomes of polypharmacy
10.1177/2042098620933741 · ExternalCitation · doi-reference
What is polypharmacy? A systematic review of definitions
10.1186/s12877-017-0621-2 · ExternalCitation · doi-reference
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
10.1186/s13643-021-01626-4 · ExternalCitation · doi-reference
Policies for deprescribing: an international scan of intended and unintended outcomes of limiting sedative-hypnotic use in community-dwelling older adults
10.12927/hcpol.2019.25857 · ExternalCitation · doi-reference
Clinical consequences of polypharmacy in elderly
10.1517/14740338.2013.827660 · ExternalCitation · doi-reference
Pilot randomized trial of a pharmacy intervention for older adults with cancer
10.1634/theoncologist.2018-0408 · ExternalCitation · doi-reference
Associations of polypharmacy and inappropriate medications with adverse outcomes in older adults with cancer: a systematic review and meta-analysis
10.1634/theoncologist.2019-0406 · ExternalCitation · doi-reference
10.18773/austprescr.2025.055
10.18773/austprescr.2025.055 · ExternalCitation · doi-reference
Prescription of potentially inappropriate medication in older inpatients of an internal medicine ward: concordance and overlap among the EU(7)-PIM list and beers and STOPP criteria
10.3389/fphar.2021.676020 · ExternalCitation · doi-reference
Impact of a tripartite collaboration between oncologist, pharmacist and diabetologist in the management of patients with diabetes starting chemotherapy: the ONCODIAB trial
10.3390/cancers15184544 · ExternalCitation · doi-reference
Deprescribing: a prime opportunity to optimize care of cancer patients
10.3390/curroncol30110704 · ExternalCitation · doi-reference
